Zimmer Biomet Holdings
medical device company
ZBH NYSE · home listing
ZBH SIX Swiss
ISIN US98956P1021 SEC CIK 1136869 LEI 2P2YLDVPES3BXQ1FRB91
Follow Zimmer Biomet
Weekly email: filings, results
Revenue, last quarter
$2.1B
+3.1% vs same quarter last year
Net income
$191.6M
−17% vs same quarter last year
EPS, diluted
$1.00
−13.8% vs same quarter last year
Operating cash flow
$560M
+33.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $8.2B | $705.1M |
| FY24 | $7.7B | $903.8M |
| FY23 | $7.4B | $1B |
| FY22 | $6.9B | $231.4M |
| FY21 | $6.8B | $401.6M |
| FY20 | $6.1B | −$138.9M |
| FY19 | $7B | $1.1B |
| FY18 | $7.9B | −$379.2M |
| FY17 | $7.8B | $1.8B |
| FY16 | $7.7B | $305.9M |
| FY15 | $6B | $147M |
| FY14 | $4.7B | $720.3M |
| FY13 | $4.6B | $780.4M |
| FY12 | $4.5B | $755M |
| FY11 | $4.5B | $760.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 69.7% | 13.3% | 8.6% |
| FY24 | 71.5% | 16.7% | 11.8% |
| FY23 | 71.8% | 17.3% | 13.8% |
| FY22 | 70.9% | 10% | 3.3% |
| FY21 | 71.3% | 12.6% | 5.9% |
| FY20 | 70.2% | 1.4% | −2.3% |
| FY19 | 72.1% | 16% | 16.3% |
| FY18 | 71.4% | 0.4% | −4.8% |
| FY17 | 72.7% | 10.2% | 23.2% |
| FY16 | 68.9% | 10.7% | 4% |
| FY15 | 70% | 7.8% | 2.5% |
| FY14 | 73.3% | 22.2% | 15.4% |
| FY13 | 72.2% | 23.1% | 16.9% |
| FY12 | 74.8% | 23.4% | 16.9% |
| FY11 | 74.8% | 23% | 17.1% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.5B |
| FY24 | $1.3B |
| FY23 | $1.3B |
| FY22 | $1.2B |
| FY21 | $1.4B |
| FY20 | $1.1B |
| FY19 | $1.4B |
| FY18 | $1.6B |
| FY17 | $1.4B |
| FY16 | $1.4B |
| FY15 | $682.1M |
| FY14 | $915.6M |
| FY13 | $863.1M |
| FY12 | $1B |
| FY11 | $1.1B |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $190.3M | $487M |
| FY24 | $196M | $868M |
| FY23 | $200.9M | $692.2M |
| FY22 | $201.2M | $126.4M |
| FY21 | $200.1M | - |
| FY20 | $198.5M | - |
| FY19 | $196.7M | - |
| FY18 | $195.2M | - |
| FY17 | $193.6M | - |
| FY16 | $188.4M | $415.5M |
| FY15 | $157.1M | $150M |
| FY14 | $145.5M | $400.9M |
| FY13 | $132.4M | $720.8M |
| FY12 | $94.4M | $485.6M |
| FY11 | - | $1.1B |
- Zimmer Biomet
- Healthcare median
Show the numbers
| Year | Zimmer Biomet | Healthcare median |
|---|---|---|
| FY25 | 8.6% | −30.6% |
| FY24 | 11.8% | −47% |
| FY23 | 13.8% | −58% |
| FY22 | 3.3% | −80.4% |
| FY21 | 5.9% | −71.9% |
| FY20 | −2.3% | −62.2% |
| FY19 | 16.3% | −46.3% |
| FY18 | −4.8% | −49.6% |
| FY17 | 23.2% | −45.9% |
| FY16 | 4% | −36% |
| FY15 | 2.5% | −38.4% |
| FY14 | 15.4% | −35.5% |
| FY13 | 16.9% | −37.1% |
| FY12 | 16.9% | −29.1% |
| FY11 | 17.1% | −27.9% |